Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Forns

Showing results (1-10 of 298) with videos related to

Pageof 30
Sort By:
Hepatology (Baltimore, Md.)|February 15, 2017
Juan Rodés, M.D., Ph.D. (1938-2017): Excellence and leadershipXavier Forns
Hepatology (Baltimore, Md.)|December 1, 2005
HCV: alive and kicking in living donor liver grafts?Xavier Forns
Gastroenterologia Y Hepatologia|November 2, 2020
Red yeast rice extract: The risky trend of natural productsGuillem Soy, Xavier Forns
Journal of Hepatology|June 13, 2018
Treatment of chronic hepatitis CXavier Forns, Christoph Sarrazin
Enfermedades Infecciosas Y Microbiologia Clinica|October 16, 2004
[Current epidemiology of viral hepatitis: who is affected and who can be protected?]Miquel Bruguera, Xavier Forns
Journal of Hepatology|December 13, 2006
Antiviral therapy in HCV decompensated cirrhosis: to treat or not to treat?Miquel Navasa, Xavier Forns
Journal of Hepatology|March 26, 2010
Treating hepatitis C in patients with cirrhosis: the effort is worth itXavier Forns, Jordi Bruix
The Lancet. Gastroenterology & Hepatology|July 13, 2023
More is not always better for novel hepatitis B therapiesSabela Lens, Xavier Forns
Enfermedades Infecciosas Y Microbiologia Clinica|September 26, 2013
[Telaprevir in HCV-monoinfected patients with failure to prior treatment]Ricard Solà, Xavier Forns
Gastroenterologia Y Hepatologia|July 11, 2020
Liver transplant immunosuppression during the covid-19 pandemicXavier Forns, Miquel Navasa
Pageof 30

Showing results (1-10 of 298) with videos related to

Sort By:
Pageof 30
Hepatology (Baltimore, Md.)|February 15, 2017
Juan Rodés, M.D., Ph.D. (1938-2017): Excellence and leadershipXavier Forns
Hepatology (Baltimore, Md.)|December 1, 2005
HCV: alive and kicking in living donor liver grafts?Xavier Forns
Gastroenterologia Y Hepatologia|November 2, 2020
Red yeast rice extract: The risky trend of natural productsGuillem Soy, Xavier Forns
Journal of Hepatology|June 13, 2018
Treatment of chronic hepatitis CXavier Forns, Christoph Sarrazin
Enfermedades Infecciosas Y Microbiologia Clinica|October 16, 2004
[Current epidemiology of viral hepatitis: who is affected and who can be protected?]Miquel Bruguera, Xavier Forns
Journal of Hepatology|December 13, 2006
Antiviral therapy in HCV decompensated cirrhosis: to treat or not to treat?Miquel Navasa, Xavier Forns
Journal of Hepatology|March 26, 2010
Treating hepatitis C in patients with cirrhosis: the effort is worth itXavier Forns, Jordi Bruix
The Lancet. Gastroenterology & Hepatology|July 13, 2023
More is not always better for novel hepatitis B therapiesSabela Lens, Xavier Forns
Enfermedades Infecciosas Y Microbiologia Clinica|September 26, 2013
[Telaprevir in HCV-monoinfected patients with failure to prior treatment]Ricard Solà, Xavier Forns
Gastroenterologia Y Hepatologia|July 11, 2020
Liver transplant immunosuppression during the covid-19 pandemicXavier Forns, Miquel Navasa
Pageof 30